CD34 is expressed in all endothelial cells during proliferation as well as in the G0 stage, and anti-CD34 Abs react with the largest number of endothelial cells compared to other antibodies used in studies of tumor angiogenesis. This evidence concerns the gene CD34 and neoplasm.